# A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

> **NCT01371994** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 640 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** solifenacin succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01371994
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-02
- **Primary completion:** 2013-10-21
- **Final completion:** 2013-10-21
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371994, "A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01371994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*